In this study, we verified that HT-29 colon cancer cells were inhibited by LLEFE via regulation of the PI3K/Akt signaling pathway in vitro. We also elucidated the relationship between the active components of LLEFE and the regulation of the PI3K/Akt signaling pathway. The gene discussed is AKT1; the disease is colonic neoplasm.